Non-Invasive Monitoring Systems (NIMU) Aktie Kurs
Non-Invasive Monitoring Systems Kurs
Omsætningen i Non-Invasive Monitoring Systems er faldet med 32,6 % om året de seneste 10 år til 6.000,00 USD. For Non-Invasive Monitoring Systems er nettoavance på -8.133,3 % ned i forhold til -221,6 % for et par år siden.
Non-Invasive Monitoring Systems aktiekurs
Non-Invasive Monitoring Systems aktie og aktieanalyse
Hyppigt stillede spørgsmål om Non-Invasive Monitoring Systems-aktien
Non-Invasive Monitoring Systems Inc (NIMS) primarily operates in the healthcare industry.
The main competitors of Non-Invasive Monitoring Systems Inc in the market include companies like Medtronic, Masimo Corporation, and Edwards Lifesciences Corporation.
The business model of Non-Invasive Monitoring Systems Inc is centered around the development and commercialization of non-invasive, medical monitoring technologies and products. The company aims to provide innovative solutions for monitoring vital signs, such as blood pressure, heart rate, and oxygen saturation, without the need for invasive procedures. Non-Invasive Monitoring Systems Inc focuses on creating advanced and user-friendly devices that enhance patient care and improve medical outcomes. With a commitment to research and development, the company strives to revolutionize the healthcare industry by offering non-invasive monitoring solutions that are accurate, reliable, and accessible to healthcare professionals and patients alike.
Non-Invasive Monitoring Systems Inc is a company specializing in non-invasive medical monitoring technology. Founded in [year], the company has worked diligently to develop innovative and cutting-edge monitoring systems. With a focus on patient comfort and accuracy, Non-Invasive Monitoring Systems Inc has become a trusted name in the medical industry. The company's expertise lies in creating non-invasive solutions that provide reliable data without the need for invasive procedures. Continuously striving for advancements, Non-Invasive Monitoring Systems Inc aims to improve the quality of healthcare by providing healthcare professionals with state-of-the-art monitoring technology.
Non-Invasive Monitoring Systems Inc (NIMS) has achieved several significant milestones. Firstly, NIMS successfully developed and patented innovative non-invasive monitoring technologies, positioning the company as a leader in this field. Additionally, NIMS established strategic partnerships with renowned hospitals and research institutions, enabling the company to conduct extensive clinical trials and validate the effectiveness of their products. Furthermore, NIMS secured regulatory clearances for its monitoring devices, demonstrating their commitment to meeting industry standards. Moreover, NIMS has expanded its global presence, entering new markets and reaching a wider customer base. These achievements solidify NIMS' position as a pioneering company revolutionizing non-invasive monitoring solutions.
Non-Invasive Monitoring Systems Inc primarily maintains its presence in the United States.
Non-Invasive Monitoring Systems Inc represents a values-driven corporate philosophy focused on innovation, accuracy, and patient-centricity. The company's commitment to non-invasive monitoring solutions underscores its dedication to improving healthcare outcomes and enhancing patient experience. With a focus on cutting-edge technology, Non-Invasive Monitoring Systems Inc continually strives to develop advanced medical devices that provide accurate and real-time data to healthcare professionals. By prioritizing patients' well-being, the company aims to contribute to the overall improvement of healthcare delivery. Non-Invasive Monitoring Systems Inc's corporate philosophy emphasizes its dedication to advancing medical practices through innovative solutions and a patient-centered approach.
Omregnet til den aktuelle valutakurs handles Non-Invasive Monitoring Systems-aktien til 11,88 EUR (13,31 USD).
The Non-Invasive Monitoring Systems Inc. offers an innovative business model specializing in non-invasive medical monitoring systems and diagnostic procedures. The company has made significant progress in the development and introduction of devices in recent years that allow medical professionals to apply non-invasive methods for monitoring and diagnosing patients. The company's core competency lies in the design, development, and marketing of medical devices and software that enable physicians to monitor patients' vital signs without the need for invasive measures. This includes systems for monitoring blood pressure, heart rate, oxygen saturation, and other physiological parameters. One of Non-Invasive Monitoring Systems' key areas is telemedicine. The company's devices are used to capture patients' vital signs in real-time and transmit them to medical professionals. This enables doctors to care for patients without direct physical contact, which is particularly advantageous during pandemics such as COVID-19. Another division of the company is research and development in the fields of artificial intelligence and big data analysis to improve the diagnosis and prediction of diseases. The company collaborates closely with experts in medicine and technology to develop new diagnosis and monitoring systems based on the current needs of patients and medical professionals. The company offers a wide range of products, including portable devices such as blood pressure monitors, heart rate monitors, and oxygen saturation monitors that are easy to use and transport. Additionally, there are diagnostic devices such as ultrasound and MRI machines. All products are manufactured with high-quality standards and at affordable prices. Overall, the business model of Non-Invasive Monitoring Systems Inc. offers promising future prospects. The demand for non-invasive monitoring and diagnostic systems is steadily growing, and the company is well-positioned to meet these requirements. Through consistent focus on new technologies and research collaborations, the company will undoubtedly expand its portfolio and possibly expand into other markets.
Omsætningen kan for øjeblikket ikke beregnes for Non-Invasive Monitoring Systems.
-overskuddet for Non-Invasive Monitoring Systems er -222.000,00 USD. Nettooverskuddet afspejler virksomhedens rentabilitet efter fradrag af alle udgifter.
Pris-til-indtjening-forholdet (P/E) for Non-Invasive Monitoring Systems er i øjeblikket -61,91. P/E-forholdet sammenligner den nuværende aktiekurs med indtjeningen pr. aktie og hjælper investorer med at vurdere værdiansættelsen af Non-Invasive Monitoring Systems-aktien.
P/S-forholdet kan ikke beregnes for Non-Invasive Monitoring Systems i øjeblikket.
AlleAktien-kvalitetsscore for Non-Invasive Monitoring Systems er 2/10.
ISIN for Non-Invasive Monitoring Systems er US6553665083. ISIN (International Securities Identification Number) er en globalt unik identifikator for værdipapirer.
WKN for Non-Invasive Monitoring Systems er 882371. WKN (Wertpapierkennnummer) er et seks-cifret tysk identifikationsnummer for værdipapirer.
Tickeren for Non-Invasive Monitoring Systems er NIMU. Tickersymbolet bruges til at handle Non-Invasive Monitoring Systems-aktier på børsen.
Non-Invasive Monitoring Systems aktie
Non-Invasive Monitoring Systems Peer Group
Non-Invasive Monitoring Systems Ticker
Non-Invasive Monitoring Systems FIGI
Alle fundamentale data om Non-Invasive Monitoring Systems i deep dive
Vores aktieanalyse af Non-Invasive Monitoring Systems-aktien indeholder vigtige finansielle nøgletal som omsætning, profit, P/E-ratioen, P/S-ratioen, EBIT samt informationer om udbytte. Desuden ser vi på aspekter som aktier, markedskapitalisering, gæld, egenkapital og forpligtelser hos Non-Invasive Monitoring Systems. Hvis du søger mere detaljerede oplysninger om disse emner, tilbyder vi på vores undersider omfattende analyser: